Bionow is an award winning specialist business development and services company at the heart of the biomedical and life sciences sector in the North of England.
 

Bionow is a not for profit membership organisation supporting the biomedical, pharma and life sciences sectors across the North of England. Bionow does this by bringing people together at our exciting conferences and events across the North, being an advocate for the North, and providing comprehensive procurement member benefits that strengthen the competitiveness of the North’s innovative life science sector.

Our mission is to provide the tools and support for your organisation to become amongst the most competitive in the industry through our range of specialist products and services.

What our members have to say

we are reliable & trusted
As a recent affiliate of Bionow, the membership services have provided significant cost efficiency to our business ranging from services such as insurance through to regular consumables. It is critical to have an organisation which both represents and promotes the North of England’s biomedical sector; Bionow has certainly filled this space very effectively.


Ruhksana Quyoum, Director
AF ChemPharm

"Membership of Bionow has provided High Force Research with valuable networking opportunities in the life sciences resulting in a number of promising collaborations. I have no hesitation in recommending Bionow if you are looking to make lasting connections within the sector."


Jennifer Wallis, Business Development Executive
High Force Research Ltd

"Bionow has supported Allergan from our early days as a small specialist CMO through to being a strategic R&D and manufacturing site within Allergan plc, a global pharmaceutical company. Bionow provides a tailored offering for small, medium and global biomedical companies that strengthens the implementation of their business plans."


Crawford Brown PhD, Snr VP Biologics R&D
Allergan plc

"We have been members of Bionow since we started our Company. Membership has significantly raised our profile and has given us access to a great network of support to help us grow our business. We were delighted to win the Bionow Start Up of the Year Award in 2016"


Steve McConchie, CEO
Aptus Clinical

Bionow is an invaluable platform to network with innovative companies and universities throughout the UK. We would like to thank you for your continued support.


Margareta Curticapean, Sales Support Officer
Cobra Biologics

Events

See Our Upcoming Events

2021 BioCap Conference

Thursday 30th September 2021 at Digital Event

The BioCap Conference provides a unique meeting place connecting life sciences businesses, researchers and investors. Join us in navigating the life sciences funding landscape and identifying the life science investment opportunities that will advance and support the su...

The Atlantic KET Med Project is bringing new, high tech, pilot production capacity to the EU Atlantic Area in support of SMEs and start-ups leveraging the Key Enabling Technologies (KETs) to produce next generation medical devices. The Project is being delivered by seven international partners...

Bionow News

Find out what's happening in the industry

The Infection Innovation Consortium (iiCON) and its lead partner, Liverpool School of Tropical Medicine, have supported Liverpool-based SME AmDel Medical with specialist product evaluation f...

PeproTech announces 65,000 square foot expanded production facility in a multimillion dollar investment

Skills and Technical Advisory Group demonstrates how industry is at the forefront of the work of the NHC

Infex Therapeutics is pressing ahead with a major development of its pandemic resilience strategy by today announcing an agreement with CRUK Newcastle Drug Discovery Unit.

Depending on intended use, a mobile app can be considered a medical device, which can directly or indirectly impact patient or user safety. The same risk-based approach to software complianc...

Information for new potential PIPS hosts via Bionow

Explore the new features and enhancements in Flare™ FEP that improve the speed and usability of running calculations, whilst still delivering highly accurate results.

Catalent today announced the launch of its new OptiDose® Design Solution, a comprehensive assessment of your molecule, patient, and market. Designed to incorporate recommendations from our ...

Our Valued Sponsors & Partners